Firefly Neuroscience, Inc.
AIFF
$2.24
$0.2613.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.19% | 29.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.19% | 29.77% | |||
| Cost of Revenue | -4.96% | 868.00% | |||
| Gross Profit | 24.66% | -46.72% | |||
| SG&A Expenses | -4.23% | 45.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.99% | 50.93% | |||
| Operating Income | 2.12% | -54.92% | |||
| Income Before Tax | 6.06% | -44.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.03% | -43.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.03% | -43.97% | |||
| EBIT | 2.12% | -54.92% | |||
| EBITDA | 1.82% | -52.40% | |||
| EPS Basic | -2.20% | -35.11% | |||
| Normalized Basic EPS | 3.10% | -28.47% | |||
| EPS Diluted | -2.20% | -35.11% | |||
| Normalized Diluted EPS | 3.10% | -28.47% | |||
| Average Basic Shares Outstanding | 0.84% | 6.54% | |||
| Average Diluted Shares Outstanding | 0.84% | 6.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||